Daily non-political popular news in brief.
Lowering blood pressure improves diastolic dysfunction in hypertensive patients
03-25-2007 · EurekAlert!Many patients with hypertension experience stiffening of the heart muscle resulting in difficulty of the heart filling, known as diastolic dysfunction. According to study results presented today at the American College of Cardiology’s 56th Annual Scientific Session, diastolic dysfunction improved in patients with mild hypertension when treated with the blood pressure-lowering agent valsartan, as well as with other approaches to lowering blood pressure.
Read more »
Keywords: lowering, blood, pressure, improves, diastolic, dysfunction, hypertensive, patients, improve, patient
« Previous | Next »
Similar news on "Lowering blood pressure improves diastolic dysfunction in hypertensive patients":
- Clevidipine during heart surgery improves blood pressure control
03-27-2007 · EurekAlert!
Researchers today reported that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology’s 56th Annual Scientific Session. Another study found that measuring a certain peptide can help evaluate dyspnea (shortness of breath) as heart- or lung-related in the general population.
Similar news · Read more »
- Longer treatment benefits sleep apnea patients
06-06-2007 · EurekAlert!
Adults with obstructive sleep apnea benefit significantly from longer nightly use of continuous positive airway pressure (CPAP), a device to improve breathing during sleep, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. This is the first study to identify the nightly duration of CPAP use needed to gain maximum benefit for daytime alertness and functioning.
Similar news · Read more »
- Genes and drugs team up to lower blood pressure
09-12-2007 · EurekAlert!
Patients with high blood pressure respond very differently to anti-hypertensive medication, making treatment selection tricky for physicians. But new research published in the online open access journal, BMC Medical Genetics, pinpoints a number of gene-drug interactions that could allow medication to be tailored to individual patients based on their genetics.
Similar news · Read more »
- Gene variations associated with effectiveness of blood pressure medications
01-22-2008 · EurekAlert!
Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the Jan. 23 issue of JAMA.
Similar news · Read more »
- Study identifies steps to improve safety of renal artery stenting
03-26-2007 · EurekAlert!
High blood pressure is the most common chronic medical condition in the US, and the most common identifiable cause is renal artery stenosis. Renal artery stenting is a widely performed but controversial procedure for patients. Use of a platelet inhibitor may make renal artery stenting safer for patients, especially when used in combination with an embolic protection device, according to a study presented today at the American College of Cardiology's Innovation in Intervention: i2 Summit.
Similar news · Read more »
- Only half of hypertensive California adults take blood pressure-lowering drugs
09-28-2007 · EurekAlert!
About half of California adults diagnosed with high blood pressure, or hypertension, do not take medication to lower it, researchers reported today at the American Heart Association's 61st Annual Fall Conference of the Council for High Blood Pressure Research.
Similar news · Read more »
- Combination therapy stops loss of kidney function in rare genetic disease
07-25-2007 · EurekAlert!
A combination of two types of blood pressure-lowering drugs -- an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, Mass.) -- is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
Similar news · Read more »
- Occupational therapy improves quality of life for dementia patients and their carers
11-16-2006 · EurekAlert!
Occupational therapy can help to improve the ability of people with dementia to perform daily activities and can also reduce the pressure on their caregivers, says a BMJ study published today.
Similar news · Read more »
- Frequent hemodialysis at night may improve some outcomes for patients with end-stage kidney disease
09-18-2007 · EurekAlert!
Patients who received hemodialysis at night six times a week for treatment of end-stage kidney disease had improvements on certain outcomes, including reduced need for blood pressure medications and improvement in selected quality of life measures, compared to patients who received conventional hemodialysis three times weekly, according to an article in the Sept. 19 issue of JAMA.
Similar news · Read more »
- Personalized diets may offer relief to advanced cancer patients
03-09-2007 · EurekAlert!
Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
Similar news · Read more »
